Literature DB >> 10667436

Enucleation.

D M Moshfeghi1, A A Moshfeghi, P T Finger.   

Abstract

The three most common indications for enucleation are intraocular malignancy, trauma, and a blind, painful eye. Recommending enucleation is one of the most difficult therapeutic decisions in ophthalmology. In some cases of malignancy, cryotherapy, laser photocoagulation, diathermy, chemotherapy, and radiation therapy may be viable alternatives to surgery. When surgery is chosen, evisceration or exenteration may be alternatives to enucleation. Once the decision is made to perform enucleation or evisceration, the surgeon must choose from several types of implants and wrapping materials. These devices can be synthetic, autologous, or eye-banked tissues. With certain implants, the surgeon must decide when and if to drill for subsequent peg placement. In this review, the authors discuss choices, techniques, complications, and patient consent and follow-up before, during, and after enucleation. Controversies and results of the Controlled Ocular Melanoma Study are summarized.

Entities:  

Mesh:

Year:  2000        PMID: 10667436     DOI: 10.1016/s0039-6257(99)00112-5

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN: 0039-6257            Impact factor:   6.048


  37 in total

Review 1.  Retinoblastoma in a child conceived by in vitro fertilisation.

Authors:  I Lee; P T Finger; J A Grifo; A R Rausen; A Rebarber; D H Barad
Journal:  Br J Ophthalmol       Date:  2004-08       Impact factor: 4.638

2.  Whole body PET/CT imaging for detection of metastatic choroidal melanoma.

Authors:  P T Finger; M Kurli; P Wesley; L Tena; K R Kerr; A Pavlick
Journal:  Br J Ophthalmol       Date:  2004-08       Impact factor: 4.638

3.  Eyelashes on an extruding porous polyethylene orbital implant.

Authors:  Kirsten Robberecht; Lieve Berghmans; Philippe Kestelyn; Christian Decock
Journal:  Int Ophthalmol       Date:  2010-09-21       Impact factor: 2.031

4.  Bony orbital maldevelopment after enucleation.

Authors:  Yongrong Ji; Fuxiang Ye; Huifang Zhou; Qing Xie; Shengfang Ge; Xianqun Fan
Journal:  J Anat       Date:  2015-09-22       Impact factor: 2.610

5.  Orbital brachytherapy for extrascleral extension of choroidal melanoma.

Authors:  K L Lin; L B Tena; P T Finger
Journal:  Br J Ophthalmol       Date:  2006-11       Impact factor: 4.638

Review 6.  Ocular prosthesis incorporating IPS e-max press scleral veneer and a literature review on non-integrated ocular prosthesis.

Authors:  Godwin Clovis Da Costa; Meena Ajay Aras; Paul Chalakkal; Michelle Clovis Da Costa
Journal:  Int J Ophthalmol       Date:  2017-01-18       Impact factor: 1.779

7.  Temporary suture tarsorrhaphy at the time of orbital ball implantation.

Authors:  Lindsay A McGrath; Alan A McNab
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-08-01       Impact factor: 3.117

8.  Visual outcomes of vitreoretinal surgery in eyes with severe open-globe injury presenting with no-light-perception vision.

Authors:  Hani Salehi-Had; Christopher M Andreoli; Michael T Andreoli; Carolyn E Kloek; Shizuo Mukai
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-01-27       Impact factor: 3.117

9.  Epidemiologic characteristics and outcomes of open globe injury in Shanghai.

Authors:  Yong-Rong Ji; Dong-Qing Zhu; Hui-Fang Zhou; Xian-Qun Fan
Journal:  Int J Ophthalmol       Date:  2017-08-18       Impact factor: 1.779

10.  Surgical outcomes of acellular human dermal grafts for large conjunctiva defects in orbital implant insertion.

Authors:  Su-Kyung Jung; Ji-Sun Paik; Uk-Hyun Sonn; Suk-Woo Yang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-05-19       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.